Valuation : EMV Capital plc

Market Cap 14.12M 19.15M 16.5M 15.47M 26.61M 1.83B 26.69M 184M 71.62M 924M 71.9M 70.33M 3.06B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 13.09M 17.76M 15.3M 14.34M 24.67M 1.7B 24.75M 170M 66.4M 857M 66.66M 65.21M 2.84B EV / Sales 2026 *
3.82x
EV / Sales 2027 * 3.83x
Free-Float
52.46%
Yield 2026 *
-
Yield 2027 * -
1 day-0.98%
1 week-5.61%
Current month-5.61%
1 month-5.61%
3 months+1.00%
6 months-12.93%
Current year-11.40%
1 week 49.5
Extreme 49.5
54
1 month 49.5
Extreme 49.5
55
Current year 44
Extreme 44
62
1 year 40
Extreme 40
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
137
10 years 9.75
Extreme 9.75
846
Manager TitleAgeSince
Chief Executive Officer 50 30/04/2020
Director of Finance/CFO 45 30/11/2025
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 50 13/10/2019
Director/Board Member 47 08/12/2022
Chairman 61 31/01/2023
Date Insider Type Main position Quantity % Market Cap.
08/01/26 Buy 7,000 0.0250%
08/01/26 Sell 7,000 0.0250%
19/12/25 Buy

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
-0.98%-5.61%+16.09%-15.13% 19.15M
-1.41%+0.18%+75.00%+39.30% 3.82B
-0.23%+2.04%-10.45%+7.04% 3.23B
-0.43%-1.89%+33.11%+32.95% 1.92B
+0.35%+4.12%+97.60%+184.39% 1.51B
0.00%0.00%-1.72%-7.02% 731M
-1.11%+10.34%+148.83%+230.92% 617M
0.00%0.00%-3.33%-7.05% 410M
0.00%0.00%-40.68%-75.18% 391M
0.00%0.00%-0.53%-13.02% 371M
Average -0.38%-0.04%+31.39%+37.72% 1.3B
Weighted average by Cap. -0.55%+0.79%+41.30%+47.26%

Financials

2026 *2027 *
Net sales 3.43M 4.65M 4.01M 3.76M 6.46M 444M 6.48M 44.57M 17.39M 224M 17.46M 17.08M 744M 3.75M 5.09M 4.38M 4.11M 7.07M 486M 7.09M 48.77M 19.03M 245M 19.1M 18.69M 814M
Net income - -
Net Debt -1.03M -1.4M -1.2M -1.13M -1.94M -133M -1.94M -13.37M -5.22M -67.3M -5.24M -5.12M -223M 233K 316K 272K 255K 439K 30.17M 440K 3.03M 1.18M 15.23M 1.19M 1.16M 50.49M
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It focuses on generating returns for investors from the sectors and technologies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its portfolio includes AMR Bio, Wanda Health, Deeptech Recycling Technologies, EpiBone, Sofant Technologies, Q-Bot, and others. Its portfolio, Glycotest, is a liver disease diagnostics company commercializing novel and unique blood tests for life-threatening liver cancers and fibrosis-cirrhosis. ProAxsis Limited is a commercial biomarker-led research company supporting drug development and clinical research through specialist biomarker insights.
Employees
21
Date Price Change Volume
28/08/26 GBX 50.50 -0.98% 34,927
27/08/26 GBX 51.00 -1.92% 58,857
26/08/26 GBX 52.00 -1.89% 19,095
25/08/26 GBX 53.00 0.00% 3,329
24/08/26 GBX 53.00 -0.93% 37,354
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5050GBP
Average target price
1.320GBP
Spread / Average Target
+161.39%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMVC Stock